US FDA decides to approve Moderna’s Covid-19 vaccine on emergency basis: report

US FDA decides to approve Moderna’s Covid-19 vaccine on emergency basis: report

The US Food and Drug Administration (FDA) decided Thursday night to approve Moderna Inc.’s coronavirus vaccine as a matter of urgency, the Financial Times reported, citing people close to the trial.

The report comes after the FDA said it had informed Moderna that it would work quickly to finalize and issue the emergency use permit for its Covid-19 vaccine candidate, according to Commissioner Stephen Hahn.

On Thursday, a group of FDA external advisors strongly supported the emergency use of the Moderna vaccine candidate, providing virtually a second option for protection against Covid-19 for a pandemic nation.

Covid-19 surge pushes US hospitals to brink

Meanwhile, a steady rise in coronavirus pushed besieged hospitals further, while the United States continued to launch immunizations on Thursday.

Covid-19 hospitalizations rose to record highs for the 19th day in a row, with nearly 113,000 coronavirus patients counted Wednesday in U.S. medical institutions nationwide, while another 3,580 died, mostly in one day.

The virus has claimed nearly 308,000 lives in the United States so far, and health experts have warned of a deepening crisis this winter as intensive care units (ICUs) have filled and hospital beds have collapsed. they spilled into the hallways.

“We expect to have more corpses than we have space for them,” Los Angeles Mayor Eric Garcetti said Thursday in a briefing, adding that the country’s second-largest city has completely exhausted its intensive care capacity. .

Some health workers wary of vaccine

The first 2.9 million doses of Pfizer / BioNTech vaccine began to be delivered on Sunday and were still going to hospitals across the country and in the arms of doctors, nurses and other medical professionals.

Some of the first photos were also for residents and staff of long-term care institutions. Later, vaccination rounds will go to other key workers, the elderly and people with chronic health conditions.

It will be several months before the vaccines become available to the public upon request, and opinion polls have found that many Americans are reluctant to inoculate.

Some are skeptical about immunizations in general, and others are paying attention to the unprecedented speed with which the first vaccines were developed and launched – 11 months after the first cases documented in the US by Covid-19.

Public health authorities have tried to reassure Americans that vaccines are safe as well as extremely effective in preventing disease.

But ambivalence has even appeared among the pockets of health workers designated as the first in line for inoculation.

“Some are on the fence. Some think we need to do it. It’s split in two,” said Diego Montes Lopez, 28, a phlebotomist at Martin Luther King Jr. Community Hospital in South Los Angeles, about co-workers after was injected alone.

Public service messages about vaccines have been mixed with urgent calls for Americans to remain diligent about social distancing and wearing a mask until immunizations become widely available.

They point to data showing that infections continue to spread virtually uninterrupted across much of the country, apparently fueled by increased virus transmission, as many Americans ignored warnings to avoid social gatherings and unnecessary travel during Thanksgiving last month.

Leave a Comment

You cannot copy content of this page